4 free views remaining today
T-cell acute lymphoblastic leukemia
ICD-10 Codes
Related ICD-10:
Description
What is T-cell Acute Lymphoblastic Leukemia (T-ALL)?
T-cell acute lymphoblastic leukemia (T-ALL) is a rare and aggressive type of blood cancer that affects the bone marrow, where immature white blood cells called T-cells are produced. This condition is characterized by an overproduction of abnormal T-cells, which can crowd out normal white blood cells and lead to various complications.
Key Characteristics:
- Aggressive nature: T-ALL is a fast-growing cancer that requires prompt treatment.
- Immature white blood cells: The disease involves the proliferation of immature T-cells in the bone marrow and blood.
- Bone marrow involvement: The cancer affects the bone marrow, leading to an accumulation of abnormal T-cells.
Symptoms:
- Bleeding from the gums
- Bone pain
- Fever
- Frequent infections
- Frequent or severe nosebleeds
- Lumps caused by swollen lymph nodes in and around the neck, armpits, and groin
Prevalence: T-ALL accounts for about 15% of all acute lymphoblastic leukemia (ALL) cases in pediatric patients and approximately 25% in adult cohorts.
Biological Distinctions:
- T-ALL is biologically distinct from its B lymphoblastic (B-ALL) counterpart, showing different kinetic patterns of disease response.
- Although similar treatment regimens are used for both T-ALL and B-ALL, distinctions in response to therapy have been observed.
References: [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14]
Additional Characteristics
- T-cell acute lymphoblastic leukemia (T-ALL) is a rare and aggressive type of blood cancer that affects the bone marrow, where immature white blood cells called T-cells are produced.
- The disease involves the proliferation of immature T-cells in the bone marrow and blood.
- T-ALL accounts for about 15% of all acute lymphoblastic leukemia (ALL) cases in pediatric patients and approximately 25% in adult cohorts.
- T-ALL is biologically distinct from its B lymphoblastic (B-ALL) counterpart, showing different kinetic patterns of disease response.
Signs and Symptoms
Diagnostic Tests
Diagnostic Tests for T-cell Acute Lymphoblastic Leukemia (T-ALL)
T-cell acute lymphoblastic leukemia (T-ALL) is a type of cancer that affects the bone marrow and blood. Diagnosing T-ALL requires a series of tests to confirm the presence of abnormal T-cells in the bone marrow.
Tests Used to Diagnose T-ALL:
- Blood Tests: Blood tests are used to count the number of platelets, white blood cells, and red blood cells. These tests can also measure liver and kidney function and detect signs of inflammation and infection [5].
- Bone Marrow Biopsy: A bone marrow biopsy is a procedure where a sample of bone marrow is taken from the hipbone using a needle. This test can help diagnose T-ALL by identifying abnormal T-cells in the bone marrow [6].
- Sophisticated Genetic Testing: NYU Langone doctors use advanced genetic testing to diagnose T-ALL, including tests that identify specific genetic mutations and translocations [7].
- Flow Cytometry: Flow cytometry is a test that uses fluorescent dyes to detect specific proteins on the surface of cells. This test can help identify abnormal T-cells in the bone marrow [8].
Additional Tests:
- Polymerase Chain Reaction (PCR) Testing: PCR testing is used to determine the amount of minimal residual disease (MRD) in patients with T-ALL. MRD refers to the presence of cancer cells that are not detectable by standard tests [13].
- Immunophenotyping: Immunophenotyping is a test that uses antibodies to identify specific proteins on the surface of cells. This test can help diagnose T-ALL and determine the subtype of leukemia [9].
References:
[5] - Blood tests may reveal too many or too few white blood cells, not enough red blood cells, and not enough platelets. [6] - A bone marrow biopsy is a procedure where a sample of bone marrow is taken from the hipbone using a needle. [7] - NYU Langone doctors use advanced genetic testing to diagnose T-ALL, including tests that identify specific genetic mutations and translocations. [8] - Flow cytometry is a test that uses fluorescent dyes to detect specific proteins on the surface of cells. [9] - Immunophenotyping is a test that uses antibodies to identify specific proteins on the surface of cells. [13] - PCR testing is used to determine the amount of minimal residual disease (MRD) in patients with T-ALL.
Additional Diagnostic Tests
- Blood Tests
- Polymerase Chain Reaction (PCR) Testing
- Bone Marrow Biopsy
- Immunophenotyping
- Flow Cytometry
- Sophisticated Genetic Testing
Treatment
Differential Diagnosis
Differential Diagnoses for T-cell Acute Lymphoblastic Leukemia (T-ALL)
T-cell acute lymphoblastic leukemia (T-ALL) is a type of cancer that affects the white blood cells. When diagnosing T-ALL, it's essential to consider other conditions that may present with similar symptoms or laboratory findings. Here are some differential diagnoses for T-ALL:
- Adult T-cell leukemia/lymphoma: This is a rare and aggressive form of blood cancer that affects adults. It's characterized by the proliferation of mature T-cells in the bone marrow, lymph nodes, and other organs.
- T-cell prolymphocytic leukemia (T-PLL): This is a type of cancer that affects mature T-cells in the bone marrow and peripheral blood. It's often associated with a high white blood cell count and anemia.
- Sézary syndrome: This is a rare skin condition characterized by the presence of malignant T-cells in the skin, lymph nodes, and other organs.
- Anaplastic large-cell lymphoma (ALCL): This is a type of non-Hodgkin lymphoma that affects mature T-cells. It's often associated with a high white blood cell count and anemia.
These conditions can be challenging to distinguish from T-ALL based on clinical presentation alone. Laboratory tests, such as flow cytometry and molecular analysis, are essential for accurate diagnosis.
References:
- [3] Adult T-cell leukemia/lymphoma is mentioned as one of the differential diagnoses for T-ALL.
- [4] T-cell prolymphocytic leukemia (T-PLL) is listed as a type of cancer that affects mature T-cells in the bone marrow and peripheral blood.
- [8] Sézary syndrome is described as a rare skin condition characterized by the presence of malignant T-cells in the skin, lymph nodes, and other organs.
- [9] Anaplastic large-cell lymphoma (ALCL) is mentioned as a type of non-Hodgkin lymphoma that affects mature T-cells.
Additional Information
- rdf-schema#subClassOf
- http://purl.obolibrary.org/obo/DOID_9952
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_2949
- owl#annotatedSource
- t437537
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#hasAlternativeId
- DOID:715
- oboInOwl#id
- DOID:5603
- core#notation
- DOID:5603
- oboInOwl#hasDbXref
- UMLS_CUI:C0023492
- oboInOwl#hasExactSynonym
- T-cell lymphoblastic leukemia/lymphoma
- IAO_0000115
- An acute lymphoblastic leukemia that is characterized by too many T-cell lymphoblasts found in the bone marrow and blood.
- rdf-schema#label
- T-cell acute lymphoblastic leukemia
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/doid#DO_cancer_slim
- relatedICD
- http://example.org/icd10/C91.0
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- owl#equivalentClass
- t437321
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.